Understanding Socially-Determined Mental Health and the Impact of COVID-19
APA president-elect Rebecca W. Brendel, MD, JD, discusses the need to prepare for a "twin mental health pandemic" while continuing to appropriately facilitate innovations in psychiatric care.
Zuranolone Benefits Major Depression, Postpartum Depression in Clinical Program
Anita Clayton, MD, reviews the available phase 2 and 3 clinical data for the novel, once-daily oral investigative drug.
The Need for Disaster Psychiatry Care
Linda Chokroverty, MD, discusses the role psychiatrists play in managing the mental health effects of disasters, and how children specifically may be impacted.
Eco-Anxiety and Contributing Mental Health Factors Among BIPOC
A pair of psychiatrists discuss how climate change and other social determinants of health are affecting the mental wellbeing of indigenous people.
Who Makes Up the Modern Dementia Care Team?
It takes even more than a village to provide the comprehensive care needed for aging, neurocognitive patients, says Rajesh R. Tampi, MD, MS.
Second-Generation Long-Acting Injectables Significantly Improve Long-Term Severe Schizophrenia Outcomes
A 6-year mirror analysis of risperidone, once-monthly paliperidone palmitate or once-monthly aripiprazole concludes suggesting the regimens may serve as an alternative to clozapine.
The Developing Dementia Definition, Treatment Field
Rajesh R. Tampi, MD, MS, discusses the evolved definition of dementia as a cognitive disorder, and how its spectrum of symptoms impact clinical development.
Drop in Suicides Won't Result in Complacency in Psychiatry
A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.
Christoph Correll, MD: An Overview of Schizophrenia Treatments
Approximately 30% of schizophrenia patients do not respond to their first treatment.
Children with ADHD May Benefit from Dextroamphetamine Transdermal Treatment
Andrew J. Cutler, MD discusses new research into the efficacy and safety of a D-ATS treatment in children with ADHD.
Anum Baig, MD: The Future of Schizophrenia Treatment
Clozapine is considered the gold standard of schizophrenia treatment.
Anum Baig, MD: Overcoming Barriers in Schizophrenia Care
Education could be the best resource in increasing prescription rates for clozapine.
Insomnia Hypnotic Treatment Lowers Risk of Suicidal Ideation
Data show zolpidem use in 8-week insomnia trial reduced suicidal ideation in patients, even after trial randomization ended.
Cognitive Impairment Associated with First-Episode Schizophrenia
New data show high rate of depressive symptoms in patients with NTFE schizophrenia.
ADHD Patients Have Higher Levels of Sleep Disturbances
Impaired reward processing could influence the presentation of sleep disturbances for patients with ADHD.
Subtle Differences in Adult ADHD Compared to Pediatric ADHD
Adults often do not suffer from the symptoms of hyperactivity in ADHD.
Higher ADHD Treatment Adherence Rates Linked to Text Message Intervention
New data show ADHD-specific text message intervention beneficial to patients who may have low rate of stimulant treatment adherence.
New Research Sheds Light on Schizophrenia Readmission Rates Following Treatment
While treatment options do not impact 30-day readmissions, they can influence hospital length of stay and costs.
DSRM Treatment Regimen Could Benefit Patients with Major Depressive Disorder
Data show effectiveness of DSRM in treating major depressive disorder with less frequent discontinuations.
Depression Forecasts Cognitive Problems in Geriatric Patients
Late life depression is a known risk factor for dementia, impacting 8-16% in the US.
Study Finds Low Stress Levels in Mental Health Workers During COVID-19 Pandemic
New data show mental health workers experienced lower levels of traumatic stress and peritraumatic distress during COVID-19 pandemic, compared to healthcare workers and general population.
Researchers Look to Improve Transition to Adult Health Care Services
The transition from pediatric care to adult care can be confusing for ADHD patients, often leading to a discontinuation of health care services altogether.
Benzodiazepine Linked to Higher Risk of Overdose in Opioid Use Disorder Treatment
Despite higher risk of adverse effects in patients with opioid use disorder, benzodiazepine does not undo protection benefits of buprenorphine.
Christoph Correll, MD: Clinical Practice Guidelines for Schizophrenia
In a poster presented at APA, researchers review current clinical practice guidelines for schizophrenia.
Dextromethadone Effective in Treatment of Major Depressive Disorder
New data show significant therapeutic effects of dextraomethadone treatment in MDD patients below the median percentage of life-years from diagnosis.
Evidence-Based Algorithms Assist Clinicians in Mood Disorder Diagnosis
A new study from APA 2021 finds algorithm use can reduce clinical misdiagnosis of bipolar disorder as other mood disorders, including major depressive disorder.
Type 1 Diabetes Mellitus Linked to Increase in ADHD Risk
The rates of both diseases have been increasingly linked in recent years.
Coping After COVID: Dealing with a Disaster
Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.
Perinatal Depression Linked to Offspring Psychosis at 18 Years
Children born to mothers who suffered from depression during pregnancy are at a greater risk of adolescent depression and psychosis.
Adjunctive Interpersonal and Social Rhythm Therapy Aids Bipolar Patients
There were no significant differences observed in mood episodes for bipolar patients in either AISR therapy or standard treatment.